Showing results (71-80 of 223) with videos related to

Sort By:
Pageof 23
The Oncologist|October 4, 2011
HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndromeVincent Sibaud, Florence Dalenc, Christine Chevreau, et al.
Clinical Lung Cancer|October 8, 2009
Pemetrexed-induced pneumonitis: a case reportYohann Loriot, Charles Ferte, Carlos Gomez-Roca, et al.
European Journal of Cancer (Oxford, England : 1990)|February 29, 2012
Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancerChristophe Massard, Isabelle Borget, Marie Cécile Le Deley, et al.
Scientific Reports|December 16, 2018
DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell deathBenoît Thibault, Ludivine Genre, Augustin Le Naour, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2018
Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumorsFrederik Marmé, Carlos Gomez-Roca, Kristina Graudenz, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2005
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFRDiane Balin-Gauthier, Jean-Pierre Delord, Philippe Rochaix, et al.
BMC Cancer|February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imagingAnne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
Breast Cancer Research and Treatment|June 16, 2014
Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case seriesVincent Sibaud, Rachel E Niec, Katja Schindler, et al.
Current Oncology (Toronto, Ont.)|May 5, 2021
Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic OptionsAnouchka Modesto, Aurore Siegfried, Amelie Lusque, et al.
Bioorganic & Medicinal Chemistry|June 15, 2010
Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluationSéverine Brillouet, Sandra Dorbes, Frédéric Courbon, et al.
Pageof 23